"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...
The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...
Irish Examiner on MSN20h
Pfizer may bring some overseas manufacturing to US if required, says chief execIf something happens, we will try to mitigate by transferring from manufacturing sites outside to manufacturing sites here' ...
Albert Bourla, the CEO of Pfizer, stated that the company is prepared to move its overseas manufacturing to the U.S. if ...
Irish Independent on MSN19h
Pfizer says more drugs can be made in its US plants for domestic market, if neededPfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply ...
The pharmaceutical industry is undergoing a paradigm shift, driven by cutting-edge technologies and new digital capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback